Physician profile
Clark Kramer
NPI 1962403436
$841.12
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $691 · 2020: $107 · 2021: $43.31.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $207.73 | 2019-2020 | |
| Tris Pharma INC | $185.17 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $71.18 | 2019-2020 | |
| Shire North American Group INC | $67.55 | 2019 | |
| Merck Sharp & Dohme LLC | $45.23 | 2019-2020 | |
| Tetraphase Pharmaceuticals, INC. | $42.41 | 2019 | |
| Janssen Biotech, INC. | $33.75 | 2020 | |
| Pfizer INC. | $25.96 | 2019-2020 | |
| Rhodes Pharmaceuticals L.P. | $23.04 | 2019 | |
| Kaleo, INC. | $20.51 | 2019 | |
| Vyera Pharmaceuticals, LLC | $17.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.71 | 2019 | |
| Sanofi Pasteur INC. | $15.97 | 2019 | |
| Adlon Therapeutics L.P. | $15.46 | 2021 | |
| Philips North America LLC | $15.06 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $13.79 | 2019 | |
| Mayne Pharma Commercial LLC | $13.69 | 2019 | |
| Amag Pharmaceuticals, INC. | $10.91 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clark Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.